Comparative histological specimen adequacy and tolerability of endoscopic versus Baby Tischler forceps for anal canal biopsy during high-resolution anoscopy in people with HIV

Objectives Anal canal cancer is strongly associated with high-risk human papillomavirus infection and occurs at increased incidence in people living with HIV. High-resolution anoscopy (HRA) with directed biopsy is the reference standard for diagnosing histological high-grade squamous intraepithelial lesions (HSIL). Comparative data on diagnostic performance and tolerability of different biopsy forceps are limited. Methods We conducted an observational single-centre non-randomised study comparing endoscopic forceps (EF) and Baby Tischler forceps (BTF) for anal canal biopsy during HRA. Histological specimen adequacy was defined as the proportion of biopsies yielding adequate histopathological specimens. Tolerability was assessed using a visual analogue scale (VAS). Short-term adverse events were systematically recorded. Investigators also completed an exploratory structured poststudy assessment of procedural handling, bleeding control, feasibility of multiple biopsies and overall instrument preference. Results A total of 244 participants underwent 365 biopsies (208 with EF and 157 with BTF). Overall, 348/365 biopsies (95.3%) yielded adequate specimens, with no significant difference between EF and BTF (96.6% vs 93.6%; p=0.272). HSIL was detected more frequently in biopsies obtained with BTF than EF (50.3% vs 26.4%; p<0.001). Clinically relevant pain (VAS score ≥5) was similar between groups (8.17% vs 8.28%; p=1.00). Any postbiopsy adverse event occurred in 42.3% of EF and 41.1% of BTF procedures (p=0.958), and all events were mild and self-limited. Investigator-reported assessment favoured EF, particularly regarding handling and bleeding control. Conclusions EF and BTF demonstrated similarly high specimen adequacy and comparable short-term safety for anal canal biopsy during HRA. Clinically relevant pain did not differ between instruments. The higher HSIL detection rate observed with BTF should be interpreted cautiously given the non-randomised design and potential operator-related and procedural confounding. Further prospective studies are warranted.

Authors

Institutions

Publication Details

Journal
Sexually Transmitted Infections
Published
2026-09-30
DOI
https://doi.org/10.1136/sextrans-2026-057027
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Comparative histological specimen adequacy and tolerability of endoscopic versus Baby Tischler forceps for anal canal biopsy during high-resolution anoscopy in people with HIV

Iván Chivite, Irene Fuertes, Emília Sánchez, José Luís Blanco et al.
Sexually Transmitted Infections
Cervical Cancer and HPV Research
article

Comparative histological specimen adequacy and tolerability of endoscopic versus Baby Tischler forceps for anal canal biopsy during high-resolution anoscopy in people with HIV

Iván Chivite, Irene Fuertes, Emília Sánchez, José Luís Blanco, Josep Riera‐Monroig, David García‐Hernández, Gemma Olmeda, Richard D Cranston
article en

Abstract

Objectives Anal canal cancer is strongly associated with high-risk human papillomavirus infection and occurs at increased incidence in people living with HIV. High-resolution anoscopy (HRA) with directed biopsy is the reference standard for diagnosing histological high-grade squamous intraepithelial lesions (HSIL). Comparative data on diagnostic performance and tolerability of different biopsy forceps are limited. Methods We conducted an observational single-centre non-randomised study comparing endoscopic forceps (EF) and Baby Tischler forceps (BTF) for anal canal biopsy during HRA. Histological specimen adequacy was defined as the proportion of biopsies yielding adequate histopathological specimens. Tolerability was assessed using a visual analogue scale (VAS). Short-term adverse events were systematically recorded. Investigators also completed an exploratory structured poststudy assessment of procedural handling, bleeding control, feasibility of multiple biopsies and overall instrument preference. Results A total of 244 participants underwent 365 biopsies (208 with EF and 157 with BTF). Overall, 348/365 biopsies (95.3%) yielded adequate specimens, with no significant difference between EF and BTF (96.6% vs 93.6%; p=0.272). HSIL was detected more frequently in biopsies obtained with BTF than EF (50.3% vs 26.4%; p<0.001). Clinically relevant pain (VAS score ≥5) was similar between groups (8.17% vs 8.28%; p=1.00). Any postbiopsy adverse event occurred in 42.3% of EF and 41.1% of BTF procedures (p=0.958), and all events were mild and self-limited. Investigator-reported assessment favoured EF, particularly regarding handling and bleeding control. Conclusions EF and BTF demonstrated similarly high specimen adequacy and comparable short-term safety for anal canal biopsy during HRA. Clinically relevant pain did not differ between instruments. The higher HSIL detection rate observed with BTF should be interpreted cautiously given the non-randomised design and potential operator-related and procedural confounding. Further prospective studies are warranted.

Sexually Transmitted Infections
Hospital Clínic de Barcelona (ES), Fundació Clínic per a la Recerca Biomèdica (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Universitat Ramon Llull (ES), Universitat de Barcelona (ES)
Good health and well-being
Openalex Percentile: Top 11%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.